Sýkora I, Vortel V
Research Institute for Pharmacy and Biochemistry, Pardubice, Czech Republic.
Neoplasma. 1993;40(5):321-7.
A method of testing postnatal carcinogenicity in rats was elaborated. The substances to be tested were administered from the 1st day after birth to the 5th, 10th and 20th days of age. The subsequent supply of a substance in diet from weaning (28th day of age) up to the end of the first year of survival was an optimal combination. A total of 12 substances were tested by this method. For all substances it was possible to provide a comparison with the results of long-term studies. For nine substances carcinogenicity was demonstrated in both tests, out of them in eight cases in identical organ systems. In three cases no carcinogenicity was ascertained in the postnatal study, in two compounds identical negative results were obtained by the two approaches. In one case (the cytostatic TS-160) development of sarcomas was found at the site of subcutaneous administration in the long-term study, and this effect was not observed in the postnatal study. Results identical for the two methods (carcinogenic or noncarcinogenic) were achieved in 11 substances, i.e. 91.7%. In addition, in 10 compounds, for which carcinogenicity was demonstrated either in the postnatal study or in the long-term study, the occurrence of tumors was found in identical organ systems after 8 compounds which is an 80% agreement. In mice, this identity of organs was demonstrated only in 62.5% of the compounds tested. The present results demonstrated that the use of postnatal carcinogenicity test in rats offers the determination of possible carcinogenic effect of the compound tested with a high probability, under economically more advantageous conditions, and with almost the same qualitative results as with the use of the long-term tests for carcinogenicity.
阐述了一种在大鼠中测试产后致癌性的方法。待测试的物质在出生后第1天至5日龄、10日龄和20日龄时给药。从断奶(28日龄)直至存活的第一年末,在饮食中持续供应一种物质是一种最佳组合。通过该方法共测试了12种物质。对于所有物质,都能够将结果与长期研究的结果进行比较。在两项测试中,有9种物质显示出致癌性,其中8种情况是在相同的器官系统中。在三项测试中,产后研究未确定致癌性,两种化合物通过两种方法均获得相同的阴性结果。在一个案例(细胞抑制剂TS - 160)中,长期研究发现在皮下给药部位出现肉瘤,而在产后研究中未观察到这种效应。11种物质(即91.7%)的两种方法(致癌或非致癌)结果相同。此外,在10种化合物中,在产后研究或长期研究中显示出致癌性,其中8种化合物在相同的器官系统中发现肿瘤,一致性为80%。在小鼠中,仅62.5%的测试化合物显示出器官相同性。目前的结果表明,在大鼠中使用产后致癌性测试能够在经济上更有利的条件下,以高概率确定受试化合物可能的致癌作用,并且定性结果几乎与使用长期致癌性测试相同。